ImmuPharma extends research ties in France; files for patents on new peptide
Proactive Investors UK
ImmuPharma said out of this collaboration it had filed patents covering a unique peptide technology platform that might be used to fight viruses.
Source: www.proactiveinvestors.co.uk
Kenneth Carnesi holds a Juris Doctor degree from New York Law School and a Professional Certificate in International Banking from Harvard Law School. Kenneth Carnesi is the Director of Operations and Government Sales at Anaptyx LLC and sits on the Boards of The Lazarus Organization, Monkeetech LLC and MG Madison Phillips, Inc. Mr. Carnesi has also founded CICG - Carnesi International Consulting Group, a company specializing in strategy consulting to small to mid-size businesses.
Kenneth Carnesi 
Leave a comment